Real-world hepatitis B antiviral treatment trends and adherence to practice guidelines: a large cohort study.
Davidov Y, Abu Baker F, Israel A, Ben Ari Z.
Davidov Y, et al. Among authors: israel a.
Acta Clin Belg. 2023 Aug;78(4):291-297. doi: 10.1080/17843286.2022.2152566. Epub 2022 Nov 30.
Acta Clin Belg. 2023.
PMID: 36448668
Antiviral therapy eligibility was met by 37% of patients, among whom 89% received antiviral therapy. Antiviral therapies include NA with a high barrier to resistance (HBR) (64.5%) and NA with a low barrier to resistance (LBR) (35.5%). ...However, one-third of them w …
Antiviral therapy eligibility was met by 37% of patients, among whom 89% received antiviral therapy. Antiviral therapies include NA with …